Published :
Tables : 55
Figures : 47
Category : Healthcare
No. of Pages : 238
Report Code : HC-U4678
Injectable Drug Delivery Market is poised to value over CAGR of over 11.3% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Injectable Drug Delivery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Injectable Drug Delivery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Injectable Drug Delivery Market: • Baxter International, Inc. • Becton, Dickinson and Company • Gerresheimer Ag • Pfizer, Inc. • Eli Lilly and Company • Sandoz (A Division of Novartis Ag) • Terumo Corporation • Teva Pharmaceutical Industries Ltd. • SHL Group • Schott AG • West Pharmaceutical Services, Inc. • Insulet Corporation • Elcam Medical • Ypsomed AG (Note: The list of the major players will be updated with the latest market scenario and trends) Injectable Drug Delivery Market Segmentation: By Type • Devices o Conventional Injection Devices o By Material o Glass o Plastic o By Product o Fillable Syringes o Prefilled Syringes o By Usability o Reusable Injection Devices o Disposable Injection Devices o Self-Injection Devices o Needle-Free Injectors o By Product o Fillable Needle-Free Injectors o Prefilled Needle-Free Injectors o By Technology o Jet-Based Needle-Free Injectors o Spring-Based Needle-Free Injectors o Laser-Powered Needle-Free Injectors o Vibration-Based Needle-Free Injectors o By Usability o Reusable Needle-Free Injectors o Disposable Needle-Free Injectors o Autoinjectors o By Product o Fillable Autoinjectors o Prefilled Autoinjectors o By Technology o Automated Autoinjectors o Manual Autoinjectors o By Design o Standardized Autoinjectors o Customized Autoinjectors o By Usability o Reusable Autoinjectors o Disposable Autoinjectors o Pen Injectors o By Product o Single-Chambered Pen Injectors o Dual-Chambered Pen Injectors o By Design o Standard Pen Injectors o Customized Pen Injectors o By Usability o Reusable Pen Injectors o Disposable Pen Injectors o Wearable Injectors o Other Devices • Formulations o Conventional Drug Delivery formulations o Solutions o Reconstituted/Lyophilized formulations o Suspensions o Emulsions o Novel Drug Delivery formulations o Colloidal Dispersions o Niosomes o Liposomes o Polymeric/Mixed Micelles o Nanoparticles o Solid-Lipid Nanoparticles o Nanosuspensions o Nanoemulsions o Microparticles o Microspheres o Microcapsules o Long-Acting Injection formulations By Formulation Packaging • Ampules • Vials • Cartridges • Bottles By Therapeutic Usage Pattern • Auto-immune diseases o Rheumatoid Arthritis o Multiple Sclerosis (Ms) o Crohn’s Disease o Psoriasis o Other Autoimmune Diseases • Hormonal Disorders o Diabetes o Anemia' o Reproductive Health Disease o Antithrombotic/Thrombolytic Therapy o Osteoporosis o Growth Hormone Deficiency (Ghd) • Orphan Diseases • Oncology • Other Therapeutic Applications o Pain Management o Allergies o Aesthetic Treatment o Hepatitis C o Hemophilia By Usage Pattern • Curative Care • Immunization • Other Usage Pattern By Site of Administration • Skin • Circulatory/Musculoskeletal • Organs • Central Nervous System By Distribution Channel • Hospitals • Retail Pharmacy Stores By Facility of Use • Hospitals & Clinics • Home Care Settings • Other Facilities of Use By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Injectable Drug Delivery Market By Type, By Formulation Packaging, By Therapeutic Usage Pattern, By Usage Pattern, By Site of Administration, By Distribution Channel, By Facility of Use and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Injectable Drug Delivery Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Injectable Drug Delivery Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Injectable Drug Delivery Market: • Baxter International, Inc. • Becton, Dickinson and Company • Gerresheimer Ag • Pfizer, Inc. • Eli Lilly and Company • Sandoz (A Division of Novartis Ag) • Terumo Corporation • Teva Pharmaceutical Industries Ltd. • SHL Group • Schott AG • West Pharmaceutical Services, Inc. • Insulet Corporation • Elcam Medical • Ypsomed AG (Note: The list of the major players will be updated with the latest market scenario and trends)
Injectable Drug Delivery Market Segmentation: By Type • Devices o Conventional Injection Devices o By Material o Glass o Plastic o By Product o Fillable Syringes o Prefilled Syringes o By Usability o Reusable Injection Devices o Disposable Injection Devices o Self-Injection Devices o Needle-Free Injectors o By Product o Fillable Needle-Free Injectors o Prefilled Needle-Free Injectors o By Technology o Jet-Based Needle-Free Injectors o Spring-Based Needle-Free Injectors o Laser-Powered Needle-Free Injectors o Vibration-Based Needle-Free Injectors o By Usability o Reusable Needle-Free Injectors o Disposable Needle-Free Injectors o Autoinjectors o By Product o Fillable Autoinjectors o Prefilled Autoinjectors o By Technology o Automated Autoinjectors o Manual Autoinjectors o By Design o Standardized Autoinjectors o Customized Autoinjectors o By Usability o Reusable Autoinjectors o Disposable Autoinjectors o Pen Injectors o By Product o Single-Chambered Pen Injectors o Dual-Chambered Pen Injectors o By Design o Standard Pen Injectors o Customized Pen Injectors o By Usability o Reusable Pen Injectors o Disposable Pen Injectors o Wearable Injectors o Other Devices • Formulations o Conventional Drug Delivery formulations o Solutions o Reconstituted/Lyophilized formulations o Suspensions o Emulsions o Novel Drug Delivery formulations o Colloidal Dispersions o Niosomes o Liposomes o Polymeric/Mixed Micelles o Nanoparticles o Solid-Lipid Nanoparticles o Nanosuspensions o Nanoemulsions o Microparticles o Microspheres o Microcapsules o Long-Acting Injection formulations
By Formulation Packaging • Ampules • Vials • Cartridges • Bottles
By Therapeutic Usage Pattern • Auto-immune diseases o Rheumatoid Arthritis o Multiple Sclerosis (Ms) o Crohn’s Disease o Psoriasis o Other Autoimmune Diseases • Hormonal Disorders o Diabetes o Anemia' o Reproductive Health Disease o Antithrombotic/Thrombolytic Therapy o Osteoporosis o Growth Hormone Deficiency (Ghd) • Orphan Diseases • Oncology • Other Therapeutic Applications o Pain Management o Allergies o Aesthetic Treatment o Hepatitis C o Hemophilia
By Usage Pattern • Curative Care • Immunization • Other Usage Pattern
By Site of Administration • Skin • Circulatory/Musculoskeletal • Organs • Central Nervous System
By Distribution Channel • Hospitals • Retail Pharmacy Stores
By Facility of Use • Hospitals & Clinics • Home Care Settings • Other Facilities of Use
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Injectable Drug Delivery Market By Type, By Formulation Packaging, By Therapeutic Usage Pattern, By Usage Pattern, By Site of Administration, By Distribution Channel, By Facility of Use and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Injectable Drug Delivery Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Injectable Drug Delivery Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Injectable Drug Delivery Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Injectable Drug Delivery Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Devices 7.1.1. Conventional Injection Devices 7.1.1.1. By Material 7.1.1.1.1. Glass 7.1.1.1.2. Plastic 7.1.1.2. By Product 7.1.1.2.1. Fillable Syringes 7.1.1.2.2. Prefilled Syringes 7.1.1.3. By Usability 7.1.1.3.1. Reusable Injection Devices 7.1.1.3.2. Disposable Injection Devices 7.1.2. Self-Injection Devices 7.1.2.1. Needle-Free Injectors 7.1.2.1.1. By Product 7.1.2.1.1.1. Fillable Needle-Free Injectors 7.1.2.1.1.2. Prefilled Needle-Free Injectors 7.1.2.1.2. By Technology 7.1.2.1.2.1. Jet-Based Needle-Free Injectors 7.1.2.1.2.2. Spring-Based Needle-Free Injectors 7.1.2.1.2.3. Laser-Powered Needle-Free Injectors 7.1.2.1.2.4. Vibration-Based Needle-Free Injectors 7.1.2.1.3. By Usability 7.1.2.1.3.1. Reusable Needle-Free Injectors 7.1.2.2.3.2. Disposable Needle-Free Injectors 7.1.2.2. Autoinjectors 7.1.2.2.1. By Product 7.1.2.2.1.1. Fillable Autoinjectors 7.1.2.2.1.2. Prefilled Autoinjectors 7.1.2.2.2. By Technology 7.1.2.2.2.1. Automated Autoinjectors 7.1.2.2.2.2. Manual Autoinjectors 7.1.2.2.3. By Design 7.1.2.2.3.1. Standardized Autoinjectors 7.1.2.2.3.2. Customized Autoinjectors 7.1.2.2.4. By Usability 7.1.2.2.4.1. Reusable Autoinjectors 7.1.2.2.4.2. Disposable Autoinjectors 7.1.2.3. Pen Injectors 7.1.2.3.1. By Product 7.1.2.3.1.1. Single-Chambered Pen Injectors 7.1.2.3.1.2. Dual-Chambered Pen Injectors 7.1.2.3.2. By Design 7.1.2.3.2.1. Standard Pen Injectors 7.1.2.3.2.2. SCustomized Pen Injectors 7.1.2.3.3. By Usability 7.1.2.3.3.1. Reusable Pen Injectors 7.1.2.3.3.2. Disposable Pen Injectors 7.1.2.4. Wearable Injectors 7.1.2.5. Other Devices 7.2. Formulations 7.2.1. Conventional Drug Delivery formulations 7.2.1.1. Solutions 7.2.1.2. Reconstituted/Lyophilized formulations 7.2.1.3. Suspensions 7.2.1.4. Emulsions 7.2.2. Novel Drug Delivery formulations 7.2.2.1. Colloidal Dispersions 7.2.2.1.1. Niosomes 7.2.2.1.2. Liposomes 7.2.2.1.3. Polymeric/Mixed Micelles 7.2.2.1.4. Nanoparticles 7.2.2.1.4.1. Solid-Lipid Nanoparticles 7.2.2.1.4.2. Nanoemulsions 7.2.2.2. Microparticles 7.2.2.2.1. Microspheres 7.2.2.2.2. Microcapsules 7.2.3. Long-Acting Injection formulations 8. Global Injectable Drug Delivery Market, By Formulation Packaging Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Ampules 8.2. Vials 8.3. Cartridges 8.4. Bottles 9. Global Injectable Drug Delivery Market, By Therapeutic Usage Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Auto-immune diseases 9.1.1. Rheumatoid Arthritis 9.1.2. Multiple Sclerosis (Ms) 9.1.3. Crohn’s Disease 9.1.4. Psoriasis 9.1.5. Other Autoimmune Diseases 9.2. Hormonal Disorders 9.2.1. Diabetes 9.2.2. Anemia' 9.2.3. Reproductive Health Disease 9.2.4. Antithrombotic/Thrombolytic Therapy 9.2.5. Osteoporosis 9.2.6. Growth Hormone Deficiency (Ghd) 9.3. Orphan Diseases 9.4. Oncology 9.5. Other Therapeutic Applications 9.5.1. Pain Management 9.5.2. Allergies 9.5.3. Aesthetic Treatment 9.5.4. Hepatitis C 9.5.5. Hemophilia 10. Global Injectable Drug Delivery Market, By Usage Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Curative Care 10.2. Immunization 10.3. Other Usage Pattern 11. Global Injectable Drug Delivery Market, By Site of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Skin 11.2. Circulatory/Musculoskeletal 11.3. Organs 11.4. Central Nervous System 12. Global Injectable Drug Delivery Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Hospitals 12.2. Retail Pharmacy Stores 13. Global Injectable Drug Delivery Market, By By Facility of Use Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Hospitals & Clinics 13.2. Home Care Settings 13.3. Other Facilities of Use 14. North America Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028 15. Latin America Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028 16. Europe Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028 17. Asia Pacific Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 18. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028 19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix 20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. Baxter International, Inc. 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Becton, Dickinson and Company 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. Gerresheimer Ag 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Pfizer, Inc. 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. Eli Lilly and Company 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. Sandoz (A Division of Novartis Ag) 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. Terumo Corporation 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. Teva Pharmaceutical Industries Ltd. 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. SHL Group 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10. Schott AG 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 20.11.West Pharmaceutical Services, Inc. 20.11.1. Company Overview 20.11.2. Product Portfolio 20.11.3. SWOT Analysis 20.11.4. Financial Overview 20.11.5. Strategic Overview 20.12.Insulet Corporation 20.12.1. Company Overview 20.12.2. Product Portfolio 20.12.3. SWOT Analysis 20.12.4. Financial Overview 20.12.5. Strategic Overview 20.13.Elcam Medical 20.13.1. Company Overview 20.13.2. Product Portfolio 20.13.3. SWOT Analysis 20.13.4. Financial Overview 20.13.5. Strategic Overview 20.14.Ypsomed AG 20.14.1. Company Overview 20.14.2. Product Portfolio 20.14.3. SWOT Analysis 20.14.4. Financial Overview 20.14.5. Strategic Overview 21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations 22. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Injectable Drug Delivery Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Injectable Drug Delivery Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Injectable Drug Delivery Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Global Injectable Drug Delivery Market, By Type Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Devices 7.1.1. Conventional Injection Devices 7.1.1.1. By Material 7.1.1.1.1. Glass 7.1.1.1.2. Plastic 7.1.1.2. By Product 7.1.1.2.1. Fillable Syringes 7.1.1.2.2. Prefilled Syringes 7.1.1.3. By Usability 7.1.1.3.1. Reusable Injection Devices 7.1.1.3.2. Disposable Injection Devices 7.1.2. Self-Injection Devices 7.1.2.1. Needle-Free Injectors 7.1.2.1.1. By Product 7.1.2.1.1.1. Fillable Needle-Free Injectors 7.1.2.1.1.2. Prefilled Needle-Free Injectors 7.1.2.1.2. By Technology 7.1.2.1.2.1. Jet-Based Needle-Free Injectors 7.1.2.1.2.2. Spring-Based Needle-Free Injectors 7.1.2.1.2.3. Laser-Powered Needle-Free Injectors 7.1.2.1.2.4. Vibration-Based Needle-Free Injectors 7.1.2.1.3. By Usability 7.1.2.1.3.1. Reusable Needle-Free Injectors 7.1.2.2.3.2. Disposable Needle-Free Injectors 7.1.2.2. Autoinjectors 7.1.2.2.1. By Product 7.1.2.2.1.1. Fillable Autoinjectors 7.1.2.2.1.2. Prefilled Autoinjectors 7.1.2.2.2. By Technology 7.1.2.2.2.1. Automated Autoinjectors 7.1.2.2.2.2. Manual Autoinjectors 7.1.2.2.3. By Design 7.1.2.2.3.1. Standardized Autoinjectors 7.1.2.2.3.2. Customized Autoinjectors 7.1.2.2.4. By Usability 7.1.2.2.4.1. Reusable Autoinjectors 7.1.2.2.4.2. Disposable Autoinjectors 7.1.2.3. Pen Injectors 7.1.2.3.1. By Product 7.1.2.3.1.1. Single-Chambered Pen Injectors 7.1.2.3.1.2. Dual-Chambered Pen Injectors 7.1.2.3.2. By Design 7.1.2.3.2.1. Standard Pen Injectors 7.1.2.3.2.2. SCustomized Pen Injectors 7.1.2.3.3. By Usability 7.1.2.3.3.1. Reusable Pen Injectors 7.1.2.3.3.2. Disposable Pen Injectors 7.1.2.4. Wearable Injectors 7.1.2.5. Other Devices 7.2. Formulations 7.2.1. Conventional Drug Delivery formulations 7.2.1.1. Solutions 7.2.1.2. Reconstituted/Lyophilized formulations 7.2.1.3. Suspensions 7.2.1.4. Emulsions 7.2.2. Novel Drug Delivery formulations 7.2.2.1. Colloidal Dispersions 7.2.2.1.1. Niosomes 7.2.2.1.2. Liposomes 7.2.2.1.3. Polymeric/Mixed Micelles 7.2.2.1.4. Nanoparticles 7.2.2.1.4.1. Solid-Lipid Nanoparticles 7.2.2.1.4.2. Nanoemulsions 7.2.2.2. Microparticles 7.2.2.2.1. Microspheres 7.2.2.2.2. Microcapsules 7.2.3. Long-Acting Injection formulations
8. Global Injectable Drug Delivery Market, By Formulation Packaging Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. Ampules 8.2. Vials 8.3. Cartridges 8.4. Bottles
9. Global Injectable Drug Delivery Market, By Therapeutic Usage Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Auto-immune diseases 9.1.1. Rheumatoid Arthritis 9.1.2. Multiple Sclerosis (Ms) 9.1.3. Crohn’s Disease 9.1.4. Psoriasis 9.1.5. Other Autoimmune Diseases 9.2. Hormonal Disorders 9.2.1. Diabetes 9.2.2. Anemia' 9.2.3. Reproductive Health Disease 9.2.4. Antithrombotic/Thrombolytic Therapy 9.2.5. Osteoporosis 9.2.6. Growth Hormone Deficiency (Ghd) 9.3. Orphan Diseases 9.4. Oncology 9.5. Other Therapeutic Applications 9.5.1. Pain Management 9.5.2. Allergies 9.5.3. Aesthetic Treatment 9.5.4. Hepatitis C 9.5.5. Hemophilia
10. Global Injectable Drug Delivery Market, By Usage Pattern Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Curative Care 10.2. Immunization 10.3. Other Usage Pattern
11. Global Injectable Drug Delivery Market, By Site of Administration Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Skin 11.2. Circulatory/Musculoskeletal 11.3. Organs 11.4. Central Nervous System
12. Global Injectable Drug Delivery Market, By Distribution Channel Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Hospitals 12.2. Retail Pharmacy Stores
13. Global Injectable Drug Delivery Market, By By Facility of Use Historical Analysis and Forecast 2022-2028 (USD Million) 13.1. Hospitals & Clinics 13.2. Home Care Settings 13.3. Other Facilities of Use
14. North America Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. U.S.A 14.2.2. Canada 14.2.3. Mexico 14.3. Market Size (USD Million) Forecast for North America 2022-2028
15. Latin America Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Brazil 15.2.2. Venezuela 15.2.3. Argentina 15.2.4. Rest of Latin America 15.3. Market Size (USD Million) Forecast for Latin America 2022-2028
16. Europe Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Germany 16.2.2. U.K 16.2.3. France 16.2.4. Italy 16.2.5. Spain 16.2.6. Russia 16.2.7. Poland 16.2.8. Rest of Europe 16.3. Market Size (USD Million) Forecast for Europe 2022-2028
17. Asia Pacific Injectable Drug Delivery Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. Japan 17.2.2. China 17.2.3. India 17.2.4. Australia and New Zealand 17.2.5. ASEAN 17.2.6. Rest of Asia Pacific 17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
18. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 18.1. Introduction 18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 18.2.1. GCC 18.2.2. Israel 18.2.3. South Africa 18.2.4. Rest of MEA 18.3. Market Size (USD Million) Forecast for MEA 2022-2028
19. Market Share Analysis and Competitive Landscape 19.1. Global Landscape - Key Players, Revenue and Presence 19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 19.3. Global Emerging Companies 19.4. North America - Market Share Analysis and Key Regional Players 19.5. Europe - Market Share Analysis and Key Regional Players 19.6. Asia Pacific - Market Share Analysis and Key Regional Players 19.7. Global Key Player - Growth Matrix
20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 20.1. Baxter International, Inc. 20.1.1. Company Overview 20.1.2. Product Portfolio 20.1.3. SWOT Analysis 20.1.4. Financial Overview 20.1.5. Strategic Overview 20.2. Becton, Dickinson and Company 20.2.1. Company Overview 20.2.2. Product Portfolio 20.2.3. SWOT Analysis 20.2.4. Financial Overview 20.2.5. Strategic Overview 20.3. Gerresheimer Ag 20.3.1. Company Overview 20.3.2. Product Portfolio 20.3.3. SWOT Analysis 20.3.4. Financial Overview 20.3.5. Strategic Overview 20.4. Pfizer, Inc. 20.4.1. Company Overview 20.4.2. Product Portfolio 20.4.3. SWOT Analysis 20.4.4. Financial Overview 20.4.5. Strategic Overview 20.5. Eli Lilly and Company 20.5.1. Company Overview 20.5.2. Product Portfolio 20.5.3. SWOT Analysis 20.5.4. Financial Overview 20.5.5. Strategic Overview 20.6. Sandoz (A Division of Novartis Ag) 20.6.1. Company Overview 20.6.2. Product Portfolio 20.6.3. SWOT Analysis 20.6.4. Financial Overview 20.6.5. Strategic Overview 20.7. Terumo Corporation 20.7.1. Company Overview 20.7.2. Product Portfolio 20.7.3. SWOT Analysis 20.7.4. Financial Overview 20.7.5. Strategic Overview 20.8. Teva Pharmaceutical Industries Ltd. 20.8.1. Company Overview 20.8.2. Product Portfolio 20.8.3. SWOT Analysis 20.8.4. Financial Overview 20.8.5. Strategic Overview 20.9. SHL Group 20.9.1. Company Overview 20.9.2. Product Portfolio 20.9.3. SWOT Analysis 20.9.4. Financial Overview 20.9.5. Strategic Overview 20.10. Schott AG 20.10.1. Company Overview 20.10.2. Product Portfolio 20.10.3. SWOT Analysis 20.10.4. Financial Overview 20.10.5. Strategic Overview 20.11.West Pharmaceutical Services, Inc. 20.11.1. Company Overview 20.11.2. Product Portfolio 20.11.3. SWOT Analysis 20.11.4. Financial Overview 20.11.5. Strategic Overview 20.12.Insulet Corporation 20.12.1. Company Overview 20.12.2. Product Portfolio 20.12.3. SWOT Analysis 20.12.4. Financial Overview 20.12.5. Strategic Overview 20.13.Elcam Medical 20.13.1. Company Overview 20.13.2. Product Portfolio 20.13.3. SWOT Analysis 20.13.4. Financial Overview 20.13.5. Strategic Overview 20.14.Ypsomed AG 20.14.1. Company Overview 20.14.2. Product Portfolio 20.14.3. SWOT Analysis 20.14.4. Financial Overview 20.14.5. Strategic Overview
21. Pre and Post COVID-19 Impact 21.1. Positive influence on the healthcare industry 21.2. The financial disruption of the manufacturing sector 21.3. Impact of COVID-19 on emerging companies 21.4. Significant mandates in the healthcare regulations initiated by administrations 21.5. The overall economic slowdown of the developing and developed nations
22. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics